VBI Vaccines Inc (VBIV): VBIV 10q https://ih.advfn.com/stock-m...

Featured News Placeholder

Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the Internation...

NASDAQ:TLSA

Stock Options

NEW to INVESTORSHUB

VBI Vaccines Inc (VBIV)

Reply Private New

Next 10 Prev Next

Send PM

Followers	67
Posts	18238
Boards Moderated	0
Alias Born	09/03/2001

FREE
VBIV REPORT

Re: None

Monday, 05/10/2021 8:14:21 AM

Monday, May 10, 2021 8:14:21 AM

VBIV 10q

https://ih.advfn.com/stock-market/NASDAQ/vbi-vaccines-VBIV/stock-news/85060040/quarterly-report-10-q

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent VBIV News

Annual Report (10-k) • Edgar (US Regulatory) • 03/13/2023 12:02:30 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 03/13/2023 12:01:23 PM
VBI Vaccines Reports Full Year 2022 Financial Results • Business Wire • 03/13/2023 12:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/28/2023 06:03:25 PM
VBI Vaccines to Discuss Progress in Hepatitis B Portfolio in Analyst-Led Fireside Chat • Business Wire • 02/23/2023 01:00:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 02/15/2023 01:01:54 PM
VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B • Business Wire • 02/15/2023 01:00:00 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:06:14 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:05:25 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:04:34 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:44 PM
Statement of Changes in Beneficial Ownership (4) • Edgar (US Regulatory) • 01/30/2023 10:02:20 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/30/2022 10:01:27 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/27/2022 01:02:11 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 12/08/2022 01:01:18 PM
VBI Vaccines Announces Health Canada Approval for PreHevbrio™ for the Prevention of Hepatitis B in Adults • Business Wire • 12/08/2022 01:00:00 PM
CEPI Boosts ‘Coronavirus X’ Vaccine Search With Expanded VBI Vaccines Deal • Business Wire • 12/06/2022 02:25:00 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/22/2022 01:00:59 PM
VBI Vaccines Presents Additional Phase 1/2a Data from VBI-1901 in Recurrent GBM at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/22/2022 01:00:00 PM
VBI Vaccines to Participate in Upcoming Investor Conferences • Business Wire • 11/14/2022 01:00:00 PM
VBI Vaccines Announces Presentation of Data from Ongoing Phase 2a Study of VBI-1901 at the 2022 Society for Neuro-Oncology (SNO) Annual Meeting • Business Wire • 11/11/2022 01:00:00 PM
Quarterly Report (10-q) • Edgar (US Regulatory) • 11/10/2022 01:01:59 PM
Current Report Filing (8-k) • Edgar (US Regulatory) • 11/10/2022 01:01:29 PM
VBI Vaccines Reports Third Quarter 2022 Financial Results and Provides Corporate Update • Business Wire • 11/10/2022 01:00:00 PM

More VBIV News

InvestorsHub NewsWire

FEATURED Tiziana Life Sciences Announces Anti-CD3 mAb Research for the Treatment of Alzheimer's Disease to be Presented by Dr. Howard Weiner at the International Conference on Alzheimer's and Parkinson's Disease and Related Neurological Disorders Conference • Mar 31, 2023 7:07 AM

ILUS Confirms Further Funding Arrangements and Note Settlement • ILUS • Mar 31, 2023 10:21 AM

Sigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-K • SIGY • Mar 31, 2023 10:06 AM

ARway Secures Multiple New SDK Deals to Drive Growth in $44B Indoor Positioning and Navigation Market • ARWYF • Mar 30, 2023 10:30 AM

Nextech3D.ai Enters Asian Market with Major 3D Modeling Deal to Revolutionize E-Commerce • NTAR • Mar 30, 2023 10:00 AM

OMID Posts 2022 Annual Report and Provides Update • OMID • Mar 30, 2023 9:15 AM

Start posting your company's news

Only $200 per official company press release!